This inventor holds 1 USPTO granted patent. Top assignee: The Cleveland Clinic Foundation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Metis Hasipek: Innovator in Bioavailable Protein Disulfide Isomerase Inhibitors
Introduction
Metis Hasipek is a notable inventor based in Cleveland, Ohio. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that serve as protein disulfide isomerase inhibitors. His work has implications for cancer treatment, showcasing the potential of innovative therapeutic approaches.
Latest Patents
Hasipek holds a patent for "Bioavailable protein disulfide isomerase inhibitors." The patent describes compounds according to a specific formula, wherein R is an amino acid or a modified amino acid linked to the compound through a peptide bond. The compounds can be utilized as protein disulfide isomerase inhibitors and may also be effective in treating cancer in subjects.
Career Highlights
Metis Hasipek is affiliated with the Cleveland Clinic Foundation, where he continues to advance research in his field. His work is characterized by a commitment to developing novel therapeutic agents that can improve patient outcomes.
Conclusion
Metis Hasipek's innovative contributions to biochemistry, particularly in the area of protein disulfide isomerase inhibitors, highlight the importance of research in developing new treatments for cancer. His work exemplifies the impact of dedicated inventors in the medical field.